Skip to main content

Cyclosporin a Therapy for Wegener’s Granulomatosis

  • Chapter
ANCA-Associated Vasculitides

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 336))

Summary

Five patients with active Wegener’s granulomatosis were treated with the immunosuppressive agent Cyclosporin A, along with low dose prednisone. All five patients had previously taken cyclophosphamide, but further treatment with this agent was not desired, either due to patient choice, drug toxicity or malignancy. In initial doses of up to 5mg/kg/day, CyA showed efficacy but when lowered to 1–2mg/kg/day, mild disease flares occurred. CyA may provide an alternative to traditional therapy in selected patients with WG.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hoffman, G.S, Kerr, G.S, Leavitt, R.Y, Hallohan, C.W. Lebovics, R.S., Travis, W.D., Rottem, M, and Fauci, A.S., 1992, Wegener granulomatosis: An analysis of 158 patients, Annals Int. Med. 116: 488–498.

    Google Scholar 

  2. Leavitt, R.Y., Fauci, A.S., Bloch, D.A., Beat, A. M., Hunder, G.G., Arend, W.P., Calabrese, L.H., Fries, J.F., Lie, J.T., Lightfoot Jr., R.W., Masi, A.T., McShane, D.J., Mills, J.A., Stevens, M.B., Wallace, S.L. and Zvaifler, N.J., 1990, The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis, Arthritis Rheum. 33: 1101–1107.

    Article  PubMed  CAS  Google Scholar 

  3. Fauci, A.S., Haynes, B.F. Katz, P., and Wolff, S., 1983, Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients from 21 years, Annals Int. Med. 98: 76–85.

    Google Scholar 

  4. deGroen, P.C., 1989, Cyclosporin: a review and its specific use in liver transplantation, Mayo Clin. Proc. 64: 680–689.

    Google Scholar 

  5. Borleffs, J.C.C., Derksen, R.H.W.M. and Hené, R.J., 1987, Treatment of Wegener’s granulomatosis with cyclosporin, Annals Rheum. Dis. 46: 175.

    Google Scholar 

  6. Harley, N., and Ihle, B., 1990, Wegener’s granulomatosis - use of cyclosporin A: a case report, Aust. N.Z. J. Med. 20: 71–73.

    Google Scholar 

  7. Gremmel, F., Druml, W., Schmidt, P. and Graninger, W., 1988, Cyclosporin in Wegener granulomatosis, Annals Int. Med. 198: 491.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Allen, N.B., Caldwell, D.S., Rice, J.R., McCallum, R.M. (1993). Cyclosporin a Therapy for Wegener’s Granulomatosis. In: Gross, W.L. (eds) ANCA-Associated Vasculitides. Advances in Experimental Medicine and Biology, vol 336. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9182-2_85

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9182-2_85

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9184-6

  • Online ISBN: 978-1-4757-9182-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics